SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 1 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,000 | +5.2% | 15,966 | +64.0% | 0.00% | – |
| Q2 2023 | $58,000 | +222.2% | 9,737 | +74.5% | 0.00% | – |
| Q1 2023 | $18,000 | -61.7% | 5,580 | -51.9% | 0.00% | – |
| Q4 2022 | $47,000 | +422.2% | 11,605 | +723.0% | 0.00% | – |
| Q3 2022 | $9,000 | +80.0% | 1,410 | +65.7% | 0.00% | – |
| Q2 2022 | $5,000 | -89.1% | 851 | -84.8% | 0.00% | – |
| Q1 2022 | $46,000 | -85.5% | 5,605 | -72.6% | 0.00% | – |
| Q4 2021 | $317,000 | +39.6% | 20,482 | +102.7% | 0.00% | – |
| Q3 2021 | $227,000 | +467.5% | 10,105 | +395.6% | 0.00% | – |
| Q2 2021 | $40,000 | +700.0% | 2,039 | +1346.1% | 0.00% | – |
| Q1 2021 | $5,000 | – | 141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |